Adsorption of fluorinated anesthetics within the pores of molecular crystals

US10117935B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10117935-B2
Application numberUS-201515534923-A
CountryUS
Kind codeB2
Filing dateDec 10, 2015
Priority dateDec 11, 2014
Publication dateNov 6, 2018
Grant dateNov 6, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of delivering or sequestering anesthetic agents by adsorption of such agents by porous partially fluorinated compounds which display high weight adsorption capacities.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of binding an anesthetic agent comprising: contacting a gas comprising an anesthetic agent with a non-covalent organic framework comprising a compound of: wherein said compound forms a porous supramolecular structure; and adsorbing said anesthetic agent within the pores of a compound of Formula 1. 2. The method of claim 1 , further comprising delivering said anesthetic agent to a patient in need thereof. 3. The method of claim 2 , further comprising sequestering said anesthetic agent from a said patient. 4. The method of claim 3 , wherein said sequestering occurs post operatively. 5. The method of claim 3 , wherein said sequestering occurs during an operative procedure. 6. The method of claim 3 , wherein said sequestering reduces toxicity. 7. The method of claim 3 wherein said sequestering reduces post-operative stress. 8. The method of claim 1 , wherein said framework has a weight adsorption capacity of about 50% to about 75% for said anesthetic agent. 9. The method of claim 1 , wherein said framework has a weight adsorption capacity of about 60 to about 65% for said anesthetic agent. 10. The method of claim 5 , wherein said anesthetic agents comprise fluorinated anesthetics, non-fluorinated anesthetics or a combination thereof. 11. The method of claim 1 , wherein the anesthetics comprise sevoflurane, enflurane, isoflurane, methoxyflurane, desflurane, halothane, or combinations thereof.

Assignees

Inventors

Classifications

  • Halogen atoms or nitro radicals · CPC title

  • acyclic, e.g. paraformaldehyde · CPC title

  • Fluorine · CPC title

  • by adsorption, e.g. preparative gas chromatography {(solid sorbent compositions B01J20/00, preparation of inorganic compounds or elements C01)} · CPC title

  • Halogenated hydrocarbons · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10117935B2 cover?
A method of delivering or sequestering anesthetic agents by adsorption of such agents by porous partially fluorinated compounds which display high weight adsorption capacities.
Who is the assignee on this patent?
Univ Houston System
What technology area does this patent fall under?
Primary CPC classification A61K47/22. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).